22.626 articles found

Does levodopa improve swallowing dysfunction in Parkinson's disease patients?

Menezes C, Melo A.

J Clin Pharm Ther · 2009-12-01

DOI: 10.1111/j.1365-2710.2009.01031.xPMID: 20175800

Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial.

Munneke M, Nijkrake MJ, Keus SH, Kwakkel G, Berendse HW, Roos RA, Borm GF, Adang EM, Overeem S, Bloem BR, ParkinsonNet Trial Study Group.

Lancet Neurol · 2009-12-01

DOI: 10.1016/s1474-4422(09)70327-8PMID: 19959398

Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study.

Kramer M, Litman R, Hough D, Lane R, Lim P, Liu Y, Eerdekens M.

Int J Neuropsychopharmacol · 2009-11-27

DOI: 10.1017/s1461145709990988PMID: 19941696

Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade.

Kerr DS.

Mol Genet Metab · 2009-11-26

DOI: 10.1016/j.ymgme.2009.11.005PMID: 20060349

Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator

CONN P JEFFREY, DILELLA ANTHONY G, KINNEY GENE G, MARINO MICHAEL J, SEABROOK GUY R, WILLIAMS DAVID L.

· 2009-11-25

PREVENTIVE AND THERAPEUTIC VACCINE FOR ALZHEIMER'S DISEASE

REDDY JEERI R.

· 2009-11-24

Therapeutic agent composition and method of use

TRAN LOI H.

· 2009-11-21

Satellite therapy delivery system for brain neuromodulation

STEVENSON ROBERT A, FRYSZ CHRISTINE, MUFFALETTO BARRY, SIEGLER ROBERT W, WINN STEVEN W, SKWARA THOMAS A, FRUSTACI DOMINICK J.

· 2009-11-18

SATELLITE THERAPY DELIVERY SYSTEM FOR BRAIN NEUROMODULATION

STEVENSON ROBERT A, FRYSZ CHRISTINE A, MUFFOLETTO BARRY C, SIEGLER ROBERT W, WINN STEVEN W, SKWARA THOMAS A, FRUSTACI DOMINICK J.

· 2009-11-16

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

NELSON GEORGE.

· 2009-11-12

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.

Meltzer HY, Mills R, Revell S, Williams H, Johnson A, Bahr D, Friedman JH.

Neuropsychopharmacology · 2009-11-11

DOI: 10.1038/npp.2009.176PMID: 19907417

Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model.

Huang R, Ke W, Liu Y, Wu D, Feng L, Jiang C, Pei Y.

J Neurol Sci · 2009-11-11

DOI: 10.1016/j.jns.2009.09.032PMID: 19909981